Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019

ROYAL LANCASTER LONDON

Why Phacilitate Leaders Europe?

Why Phacilitate Leaders Europe?

Advocating European excellence in ATMPs

Welcome to Phacilitate Leaders Europe 2019! Taking place 17th - 18th September in London, this event will bring together the entire ecosystem of the advanced therapies industry to promote the opportunities provided by the European market. 

We really believe in Europe. Whether you're an established player in the EU, or are looking to enter into the European market, there is opportunity for everyone. Join us for 2 days, 2 networking receptions, 3 content tracks, 2 partnering lunches and plenty of opportunity for 1-2-1 partnership meetings. 

Why should you attend?

Phacilitate     This is the only meeting to promote Europe as a hub for advanced therapies

Phacilitate     A European meeting that brings in the entire ecosystem across cell, gene and immuno-oncology

Phacilitate     We position networking as a priority, no an afterthought

Phacilitate     Unparalleled participation from decision-makers and budget holders

Phacilitate     The only European advanced therapies event for investors which uncovers investment opportunities whilst also serving an educational purpose

why attend phacilitate leaders europewhy attend phacilitate leaders europewhy attend phacilitate leaders europewhy attend phacilitate leaders europe

Phacilitate Leaders Europe roundtables
Phacilitate Leaders Europe speakers
Phacilitate Leaders Europe networking


Join the advanced therapies community 

Phacilitate LinkedIn Instagram Phacilitate Leaders Europe YouTube - Phacilitate Leaders Europe Twitter Phacilitate Leaders Europe

 

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd